Merck & Company, Inc. vs Orthofix Medical Inc. — Stock Comparison
Merck & Company, Inc. (MRK) and Orthofix Medical Inc. (OFIX) are both listed on US exchanges. This page compares their Q·Score ratings, key fundamentals (P/E, margins, growth), and Wall Street analyst consensus side by side. Data sourced from Yahoo Finance and updated on each page load.
Merck & Company, Inc. scores ahead of Orthofix Medical Inc. on Q·Score (7 vs 6.1 out of 10), led by Quality (7.7 vs 3.2) and Sentiment (7.1 vs 5.9). Orthofix Medical Inc. scores higher on Valuation, reflecting stronger P/E and price-target positioning. Analyst consensus targets imply greater upside for OFIX (+62.5%) than for MRK (+12.4%).
Price Performance
Normalised to 100 at period start — shows relative performance.
Q·Score Breakdown
High-quality business with 19% return on equity and 14% profit margins.
Consensus analyst target of $15.00 is 63% above current price.
⚠ currently unprofitable (-7% margin).
Analyst Consensus
Fundamentals
Frequently Asked Questions
MRK vs OFIX: which stock scores better overall?
Based on Q·Score, Merck & Company, Inc. (MRK) scores 7/10 versus Orthofix Medical Inc. (OFIX) at 6.1/10. The Q·Score measures five dimensions: Quality, Health, Growth, Valuation, and Sentiment. For informational purposes only — not financial advice.
Which has better revenue growth: MRK or OFIX?
Merck & Company, Inc. (MRK) scores higher on Growth (6.2/10 vs 5.9/10). Merck & Company, Inc. reports revenue growth (4.9% YoY) while Orthofix Medical Inc. reports (1.6% YoY). Growth scores reflect revenue and earnings momentum relative to sector peers.
Is MRK or OFIX more attractively valued?
Orthofix Medical Inc. (OFIX) scores higher on Valuation (8.6/10 vs 6.7/10). MRK trades at 12.1× P/E versus OFIX at 13.0×. Valuation is assessed using P/E ratio, analyst price targets, and 52-week range positioning relative to sector peers.
What do analysts say about MRK vs OFIX?
There are 27 analysts covering MRK with a consensus price target of $129.74, and 4 analysts covering OFIX with a consensus target of $15.00. Analyst consensus ratings are aggregated from Wall Street research and do not constitute investment advice.
Which is more profitable: MRK or OFIX?
Merck & Company, Inc. (MRK) scores higher on Quality (7.7/10 vs 3.2/10). Net profit margin: MRK at 13.6%, OFIX at -7.3%. Quality scores reflect profit margins, return on equity, and free cash flow generation.
Which has stronger financial health: MRK or OFIX?
Orthofix Medical Inc. (OFIX) scores higher on Financial Health (7.4/10 vs 7/10). Market beta: MRK at 0.22, OFIX at 0.71. Health scores consider beta, debt-to-equity, and current ratio. All investments carry risk — this is not investment advice.
What are the market caps of MRK and OFIX?
Merck & Company, Inc. (MRK) has a market capitalisation of $285.1B, while Orthofix Medical Inc. (OFIX) has a market cap of $373M. Market cap data is sourced from Yahoo Finance and reflects the most recent available figures.
Do MRK or OFIX pay dividends?
MRK pays a dividend yield of 2.95%, while OFIX does not currently pay a dividend. Dividend yields fluctuate with share price and company payout decisions.
Related Comparisons
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →